Cytokinetics Inc (NAS:CYTK)
$ 59.23 -0.91 (-1.51%) Market Cap: 6.21 Bil Enterprise Value: 6.44 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 41/100

Cytokinetics Inc Annual Shareholders Meeting Transcript

May 12, 2021 / 05:30PM GMT
Release Date Price: $24.32 (+2.31%)
Operator

Welcome, ladies and gentlemen, to the Cytokinetics 2021 Annual Stockholders' Meeting. At this time, I'd like to inform you that this meeting is being recorded. (Operator Instructions)

I'll now turn the meeting over to Pat Gage, the Chairman of Cytokinetics Board of Directors. Please go ahead.

Leonard Patrick Gage
Cytokinetics, Incorporated - Independent Chairman

Welcome, ladies and gentlemen, to our Cytokinetics 2021 Annual Meeting of Stockholders. The meeting is now called to order. Mark Schlossberg, our SVP, General Counsel and Corporate Secretary, will record the minutes.

Before proceeding to the formal business, let me introduce Robert Blum, the company's President and Chief Executive Officer, who will provide an overview of our plans for 2021 after our formal proceedings. Before proceeding, I'm pleased to introduce the members of the Cytokinetics Board of Directors, who are now here with us today: Muna Bhanji, Robert Califf, Sandy Costa, John Henderson, Ed Kaye, Lynne Parshall, Sandy Smith, Wendell Wierenga, and Nancy Wysenski.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot